Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Joachim, Pfannschmidt"'
Autor:
Pavlina Lenga, Christoph Ruwwe-Glösenkamp, Christian Grah, Joachim Pfannschmidt, Jens Rückert, Stephan Eggeling, Sven Gläser, Bernd Schmidt, Paul Schneider, Sylke Kurz, Gunda Leschber, Andreas Gebhardt, Birgit Becke, Olaf Schega, Jakob Borchardt, Ralf-Harto Hübner
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Background Endoscopic lung volume reduction (ELVR) with valves has been suggested to be the key strategy for patients with severe emphysema and concomitant low diffusing capacity of the lung for carbon monoxide (DLCO). However, robust evidence is sti
Externí odkaz:
https://doaj.org/article/090544c9048e40b98b4820e8a7993cc9
Autor:
Wessolly, Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Torsten-Gerriet Blum, Jens Kollmeier, Fabian D. Mairinger, Torsten Bauer, Joachim Pfannschmidt, Manuel Hollmann, Michael
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10558
Pulmonary sarcomatoid carcinoma (PSC) has highly aggressive biological behaviour and poor clinical outcomes, raising expectations for new therapeutic strategies. We characterized 179 PSC by immunohistochemistry, next-generation sequencing and in sili
Publikováno v:
Innovative Surgical Sciences.
Objectives In patients with non-small cell lung cancer (NSCLC) the pathologic lymph node status N2 is a heterogeneous entity, with different degrees of lymph node involvement representing different prognoses. It is speculated whether extra capsular n
Autor:
Mohammed Zoair, Samantha Taber, Roland Bittner, Gregor Foerster, Sergej Griff, Torsten T. Bauer, Joachim Pfannschmidt
Publikováno v:
Innovative Surgical Sciences. 7:35-43
Objectives The purpose of this study was to investigate the value of PET/CT in the preoperative staging of non-small cell lung cancer in predicting long-term survival and diagnostic performance, validated by histopathology following surgical resectio
Autor:
Pavlina, Lenga, Christian, Grah, Christoph, Ruwwe-Glösenkamp, Jacopo, Saccomanno, Jens, Rückert, Stephan, Eggeling, Sven, Gläser, Sylke, Kurz, Stephan, Eisenmann, Marcus, Krüger, Bernd, Schmidt, Paul, Schneider, Stefan, Andreas, Marc, Hinterthaner, Joachim, Pfannschmidt, Andreas, Gebhardt, Franz, Stanzel, Angélique, Holland, Andreas, Kirschbaum, Birgit, Becke, Ralf-Harto, Hübner
Publikováno v:
Respiration. 101:823-832
Background: Robust clinical evidence on the efficacy and safety of endoscopic lung volume reduction (ELVR) with one-way valves in patients with severe lung emphysema with chronic hypercapnic respiratory failure is lacking. Objective: The aim of this
Autor:
Heike Zabeck, Hendrik Dienemann, Hans Hoffmann, Joachim Pfannschmidt, Arne Warth, Philipp A Schnabel, Thomas Muley, Michael Meister, Holger Sültmann, Holger Fröhlich, Ruprecht Kuner, Felix Lasitschka
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0206132 (2018)
BACKGROUND:The current classification of human lung adenocarcinoma defines five different histological growth patterns within the group of conventional invasive adenocarcinomas. The five growth patterns are characterised by their typical architecture
Externí odkaz:
https://doaj.org/article/4ff071dab405416fa1f0c589a0a03db9
Autor:
Susann Stephan-Falkenau, Anna Streubel, Thomas Mairinger, Jens Kollmeier, Daniel Misch, Sebastian Thiel, Torsten Bauer, Joachim Pfannschmidt, Manuel Hollmann, Michael Wessolly, Torsten Gerriet Blum
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12511
Precision oncology and immunotherapy have revolutionized the treatment of advanced non-small-cell lung cancer (NSCLC). Emerging studies show that targeted therapies are also beneficial for patients with driver alterations such as epidermal growth fac
Autor:
Torsten T. Bauer, Joachim Pfannschmidt, Daniel Misch, Christian E. Althoff, Turna Köcer, Carolin Lips, Jens Kollmeier, Gesa Rafflenbeul, Torsten Blum
Publikováno v:
Der Nuklearmediziner. 44:42-48
ZusammenfassungDieser Übersichtsartikel stellt detailliert die derzeitigen Einsatzgebiete der Positronen-Emissions-Tomografie/Computertomografie (PET/CT) bei dem Management von Lungenkarzinom-Patient*innen dar. Hierbei werden Indikationen, Wertigkei
Autor:
Joachim Pfannschmidt, Samantha Taber
Publikováno v:
Der Nuklearmediziner. 44:55-62
ZusammenfassungDas Stadium der Oligometastasierung ist definiert als eine klinisch und radiologisch an Anzahl und Tumorvolumen limitierte und im Verlauf stabile Metastasierung. Ist das Metastasierungsausmaß auf 1 oder 2 Organsysteme und die Anzahl d
Autor:
Christian Grah, Samantha Taber, Torsten T. Bauer, Sergej Griff, Torsten Blum, Joachim Pfannschmidt
Publikováno v:
The Thoracic and Cardiovascular Surgeon. 70:244-250
Background In patients with non-small cell lung cancer (NSCLC), the pathologic union for international cancer control (UICC) stage IIIA is a heterogeneous entity, with different forms of N2-lymph node involvement representing different prognoses. Alt